HIV-positive Mothers

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99

Flash-heat treatment significantly but minimally reduced pyridoxal-5-phosphate (vitamin B6) concentration in breastmilk from HIV-positive mothers to 96% of unheated levels.

Effect: adverse; 0.96; CI: 95% CI 0.923 to 0.99